Wah-Seng Lim

Leukemia-selective uptake and cytotoxicity of CPX-351, a synergistic fixed-ratio cytarabine:daunorubicin formulation, in bone marrow xenografts

Wah-Seng Lim, Paul Tardi, Nancy Dos Santos et al. · Leukemia Research · 2010 · 155 citations

Hematological Malignancy, Leukemia-selective Uptake, Medicine +9

Signal Transducer and Activator of Transcription-1 Is Critical for Apoptosis in Macrophages Subjected to Endoplasmic Reticulum Stress In Vitro and in Advanced Atherosclerotic Lesions In Vivo

Wah-Seng Lim, Jenelle M. Timmins, Tracie A. Seimon et al. · Circulation · 2008 · 143 citations · Full text

Macrophage Apoptosis in Advanced Atherosclerosis

Ira Tabas, Tracie A. Seimon, Jenelle M. Timmins et al. · Annals of the New York Academy of Sciences · 2009 · 99 citations · Full text

Vascular Disease, Apoptosis, Immunology +19

Temporal changes in cytokine expression of foals during the first month of life

N.K. Boyd, Noah D. Cohen, Wah-Seng Lim et al. · Veterinary Immunology and Immunopathology · 2003 · 89 citations

Animal Physiology, Inflammation, Animal Reproduction +13

Schedule- and dose-dependency of CPX-351, a synergistic fixed ratio cytarabine:daunorubicin formulation, in consolidation treatment against human leukemia xenografts

Wah-Seng Lim, Paul Tardi, Xiaowei Xie et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2010 · 30 citations

Hematological Malignancy, Ratio Cytarabine, Translational Medicine +12